The role of the soluble urokinase plasminogen activator (suPAR) in children with pneumonia.

Wrotek, A; Jackowska, T

Wrotek, A; Jackowska, T.

Affiliation

Wrotek A; Department of Pediatrics, Medical Center of Postgraduate Education, 99-103 Marymoncka St., 01-813 Warsaw, Poland.
Jackowska T; Department of Pediatrics, Medical Center of Postgraduate Education, 99-103 Marymoncka St., 01-813 Warsaw, Poland; Department of Pediatrics, Bielanski Hospital, Warsaw, Poland. Electronic address: tjackowska@cmkp.edu.pl.

Respir Physiol Neurobiol ; 209: 120-3, 2015 Apr.

Article in En | MEDLINE | ID: mdl-25602915

Subject(s)

Pneumonia/metabolism; Urokinase-Type Plasminogen Activator/metabolism; Animals; Child; Humans; Lung/immunology; Pneumonia/diagnosis; Pneumonia/therapy; Urokinase-Type Plasminogen Activator/deficiency

Key words

Biomarker; CD87; CRP; Community-acquired; Invasive pneumococcal disease; Procalcitonin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Urokinase-Type Plasminogen Activator Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Child / Humans Language: En Journal: Respir Physiol Neurobiol Year: 2015 Document type: Article Affiliation country: Poland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google